Table 1 The detailed demographic and clinical characteristics of every ET-PD patient
No. | Symp. durat. | FH | Topography | Later. | Extr. tone | SN+ | Pharmacotherapy |
|---|---|---|---|---|---|---|---|
1. | 43 | Yes | H + A | D | Yes | Yes | DA, amantadine 200 mg, propranolol 80 mg |
2. | 6 | Yes | H + A | D | No | No | DA, clorazepate 10 mg |
3. | 21 | No | A + L | B | No | Yes | Propranolol 120 mg, clonazepam 2 mg |
4. | 3.5 | Yes | H + A | S | No | Yes | L-Dopa, pregabaline 75 mg |
5. | 10 | No | H + A | D | No | Yes | DA, bromazepam 1.5 mg, vit. E |
6. | 30 | Yes | H + A | D | No | No | L-Dopa |
7. | 6 | No | H + V + A | D | Yes | Yes | L-Dopa, DA, propranolol 80 mg, citalopram, |
clonazepam 0.25 mg | |||||||
8. | 10 | Yes | A + L | B | Yes | No | L-Dopa, propranolol 80 mg |
9. | 11 | No | H + A + L | B | Yes | Yes | L-Dopa, DA, rasagiline 1 mg |
10. | 15 | No | A | D | No | No | Sertraline, zolpidem |
11. | 3 | No | A | S | No | Yes | Propranolol 40 mg |
12. | 45 | Yes | A | S | No | Yes | L-Dopa, DA |
13. | 3 | Yes | H + V + A | D | No | Yes | Clonazepam 2 mg, tiapride 150 mg |
14. | 1.5 | Yes | H + A | S | No | Yes | Paroxetine, clonazepam 0.25 mg, vit. E, coenzyme Q10 |
15. | 10 | No | A | B | No | No | Gabapentine 100 mg, vinpocetine 20 mg, piracetam 400 mg, vit. E |